Cargando…
2'-Hydroxyflavanone: A novel strategy for targeting breast cancer
Breast cancer is the most common cancer in women that is driven by cross-talk with hormonal and cellular signaling pathways. The natural phytochemicals, due to broad-spectrum anti-inflammatory and anti-cancerous properties, present with novel opportunities for targeting breast cancer. Intake of citr...
Autores principales: | Singhal, Jyotsana, Nagaprashantha, Lokesh, Chikara, Shireen, Awasthi, Sanjay, Horne, David, Singhal, Sharad S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650397/ https://www.ncbi.nlm.nih.gov/pubmed/29088842 http://dx.doi.org/10.18632/oncotarget.20499 |
Ejemplares similares
-
2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer
por: Nagaprashantha, Lokesh Dalasanur, et al.
Publicado: (2018) -
Correction: 2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer
por: Nagaprashantha, Lokesh Dalasanur, et al.
Publicado: (2022) -
Anticancer activity of 2’-hydroxyflavanone towards lung cancer
por: Awasthi, Sanjay, et al.
Publicado: (2018) -
RLIP76 Regulates PI3K/Akt Signaling and Chemo-Radiotherapy Resistance in Pancreatic Cancer
por: Leake, Kathryn, et al.
Publicado: (2012) -
RLIP76, a Glutathione-Conjugate Transporter, Plays a Major Role in the Pathogenesis of Metabolic Syndrome
por: Singhal, Jyotsana, et al.
Publicado: (2011)